Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
09/2010
09/23/2010US20100240754 Unsaturated fatty amino acid derivatives and use thereof in dermal cosmetology
09/23/2010US20100240751 Methods
09/23/2010US20100240743 Cannabinoid receptor modulator
09/23/2010US20100240734 Methods and compositions for the specific inhibition of gene expression by double-stranded rna
09/23/2010US20100240717 Novel thiophene derivatives as s1p1/edg1 receptor agonists
09/23/2010US20100240690 Compositions containing opioid antagonists
09/23/2010US20100240686 Chemical compounds
09/23/2010US20100240684 Minoxidil aqueous composition containing bile acid
09/23/2010US20100240677 Compounds as PDE IV and TNF Inhibitors
09/23/2010US20100240675 Therapeutic agents useful for treating pain
09/23/2010US20100240671 Substituted heterocyclic compounds
09/23/2010US20100240664 Solubilized topoisomerase poison agents
09/23/2010US20100240660 New histone deacetylases inhibitors
09/23/2010US20100240656 Compounds as hsp90 inhibitors
09/23/2010US20100240650 Substituted pyrrolines as kinase inhibitors
09/23/2010US20100240649 Quinazoline and quinoline derivatives as irreversible protein tyrosine kinase inhibitors
09/23/2010US20100240646 Pyrrolo-triazine aniline compounds useful as kinase inhibitors
09/23/2010US20100240629 Polymorphs of fluticasone furoate and processes for preparation thereof
09/23/2010US20100240628 Skin treatments
09/23/2010US20100240623 8-oxoadenine derivatives acting as modulators of tlr7
09/23/2010US20100240621 Topical pharmaceutical composition for the combination of fusidic acid and a corticosteroid
09/23/2010US20100240614 Indole Compounds Bearing Aryl or Heteroaryl Groups Having Sphingosine 1-Phosphate (S1P) Receptor Biological Activity
09/23/2010US20100240603 Expression inhibitor of nuclear transcription factor ap-1 and pharmaceuticals and products using the same
09/23/2010US20100240590 Peptides and related molecules that bind to tall-1
09/23/2010US20100239695 Blackberry leaf extract as an active ingredient against skin irritations and inflammations
09/23/2010US20100239655 Taurine-based compositions and therapeutic methods
09/23/2010US20100239646 Sublingual methotrexate and methotrexate patches
09/23/2010US20100239645 Methods and Compositions for Wound Healing
09/23/2010US20100239643 Anti-itch sheet
09/23/2010US20100239640 Skin-derived precursor cells and uses thereof
09/23/2010US20100239639 Medicated patch
09/23/2010US20100239621 Gel sheet and cosmetic preparation in sheet form using the same
09/23/2010US20100239565 Methods of treatment of skin ulcers
09/23/2010US20100239556 Promoting ecm production by fibroblast cells and/or promoting migration of fibroblast cells in a biological system
09/23/2010US20100239544 Methods of treatment using electromagnetic field stimulated stem cells
09/23/2010US20100239530 Ifnar2 mutants, their production and use
09/23/2010US20100239520 Organic compounds
09/23/2010US20100239512 Adsorption and release of nitric oxide in metal organic frameworks
09/23/2010US20100239503 Calcium-binding agents induce hair growth and/or nail growth
09/23/2010CA2755786A1 Targets for growth factor signalling and methods of therapy
09/23/2010CA2754168A1 Fosfluconazole derivatives, synthesis, and use in long acting formulations
09/22/2010EP2230299A1 Novel cytokine ZCYTOR17 ligand
09/22/2010EP2230232A1 Addition salts of tromethamine with azabiphenylaminobenzoic acid derivatives as DHODH inhibitors
09/22/2010EP2229947A2 Use of biocompatible polymers for the preparation of a medical device or compound
09/22/2010EP2229942A1 2-Aryl-propionic acids and pharmaceutical compositions containing them
09/22/2010EP2229451A1 Materials and methods for inhibiting mammalian s-nitrosoglutathione reductase
09/22/2010EP2229377A1 5-alkyl/alkenyl-3-cyanopyridines as kinase inhibitors
09/22/2010EP2229376A1 Indole-substituted 3-cyanopyridines as kinase inhibitors
09/22/2010EP2229175A1 Composition and method for dermal regeneration
09/22/2010EP2229169A1 Preparation containing chromane-2-one derivatives
09/22/2010EP2229165A1 Anti-glycation properties of asicatic acid and madecassic acid
09/22/2010EP2229145A2 Use of a poppy petal extract for skin nutrition
09/22/2010EP2050454B1 Moisturizing agent
09/22/2010EP1809271B9 Use of (r)-(halobenzyloxy) benzylamino-propanamides as sodium and/or calcium channel selective modulators
09/22/2010EP1599464B1 Novel cyclic urea derivatives, preparation method thereof and pharmaceutical use of same as kinase inhibitors
09/22/2010EP1490374B1 Dithiolopyrrolone derivatives useful in the treatment of proliferative diseases
09/22/2010EP1147086B9 Compositions for the treatment of skin diseases
09/22/2010CN1970015B Enzymatic extraction method of pawpaw polyphenol
09/22/2010CN1947722B Blood sugar regulator used during user having meals and its preparation method
09/22/2010CN1852708B Human beta-defensin secretion promoter
09/22/2010CN1658872B Antiallergic
09/22/2010CN101842373A 6-phenyl-1h-imidazo[4,5-c]pyridine-4-carbonitrile derivatives as cathepsin inhibitors
09/22/2010CN101842355A Substituted n-aryl pyridinones as fibrotic inhibitors
09/22/2010CN101838330A Sterilized/permeability-strengthened protein-human acid fibroblast growth factor fusion protein, preparation method and application thereof
09/22/2010CN101838326A Use of the CATHELICIDIN LL-37 and derivatives thereof for wound healing
09/22/2010CN101837127A Medical use of inhibitors of glutaminyl and glutamate cyclases
09/22/2010CN101837094A External Chinese medicinal preparation for curing bedsore
09/22/2010CN101837088A Medicine for burns and scalds
09/22/2010CN101837084A Externally-used medicinal composite preparation for treating alopecia and manufacturing method thereof
09/22/2010CN101837083A Ointment for curing burns and scalds and preparation method thereof
09/22/2010CN101837082A Chinese preparation for treating burn without leaving scar
09/22/2010CN101837071A Composition of plant extracts and application in preventing or treating scars
09/22/2010CN101837068A Preparation process of zanthoxylum oil spray and application thereof
09/22/2010CN101837059A Method for preparing apple polyphenol
09/22/2010CN101837052A Herba saussureae involucratae medicinal granules and preparation method thereof
09/22/2010CN101837016A Chinese medicinal preparation for curing trauma
09/22/2010CN101837008A Ointment for curing intractable dermatosis of animals
09/22/2010CN101836965A Orally disintegrating tablet containing fexofenadine or salts of fexofenadine, and preparation method thereof
09/22/2010CN101836944A Composition of plant extracts and application in skin whitening and moisture preservation
09/22/2010CN101485625B Amoluofen emulsifiable paste
09/22/2010CN101411878B Method for anchoring growth factor on material with biodegradability
09/22/2010CN101322813B Medical ointment for treating burn
09/22/2010CN101317858B Exogenous injury ulcer treating medicine
09/22/2010CN101224275B Chinese traditional medicine for treating chloasma
09/22/2010CN101199751B Drug for treating burn, scald and preparing method thereof
09/22/2010CN101194968B Traditional Chinese medicine preparation for treating urticaria
09/22/2010CN101181612B Medicament for curing cold urticaria
09/22/2010CN101172103B Medicament for treating multiple diseases such as climacteric syndrome and osteoporosis of women
09/22/2010CN101112466B Compound composition for treating chloasma and stimulating evacuation of the bowels and uses thereof
09/21/2010US7799827 zearalenone-like macrolides, used to to inhibit nuclear factor kappa-beta (NF- kappa B) activation, as sucnscreen agents and in the treatment of inflammatory or autoimmune disorders and disorders involving malignancy or increased angiogenesis
09/21/2010US7799795 chemokine receptor modulators such as N-(1-(3-(4-cyanophenyl)-4-oxo-3,4-dihydropyrido[2,3-d]pyrimidin-2-yl)ethyl)-N-(2-(ethylsulfonyl)ethyl)-2-(4-fluoro-3-(trifluoromethyl)phenyl)-acetamide, used for the treatment of asthma, allergic and autoimmune diseases
09/21/2010US7799786 Therapeutic agents useful for treating pain
09/21/2010US7799775 Pyrimidine derivatives
09/21/2010US7799771 solid dosage form for contraceptives and hormone replacement therapy; very low moisture content to prevent ester hydrolysis; enhanced bioavailability of 17-beta-estradiol acetate; FDA Orange book listed patent for estradiol acetate
09/21/2010US7799760 Use of pharmaceutical composition containing epidermal growth factor (EGF) for diabetic foot amputation prevention
09/21/2010US7799356 Prophylaxis or treatment of inflammatory skin conditions
09/21/2010US7799338 Plaster for topical use containing heparin and diclofenac
09/21/2010US7799325 Removal of hypertrophic scars
09/21/2010CA2458415C 24-sulfur-substituted analogs of 1.alpha.,25-dihydroxy vitamin d3
09/21/2010CA2436225C N-(arylsulphonyl)beta-amino acid derivatives comprising a substituted aminomethyl group, process for preparing them and pharmaceutical compositions containing them
1 ... 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 ... 1065